InvestorsHub Logo
Followers 42
Posts 4839
Boards Moderated 0
Alias Born 04/30/2005

Re: tredenwater2 post# 359878

Tuesday, 05/10/2022 12:47:50 PM

Tuesday, May 10, 2022 12:47:50 PM

Post# of 458357
Well said, tred.

Was really impressed that they still had $150+ million in the bank.

The only reason to maintain this amount is to ensure that they can pay for future trials without having to give away a portion of the company...which is typical for milestone contracts.

Investors need to remember that the science hasn't changed!

Anavex has a huge pipeline that is maturing with each P3 trial success. We already have one P3 success with the adult Rett AVATAR trial.

Next up is the "biggie!" P2b/3 Alzheimer's trial which ends this month and has TLDR 2H of this year. (My readout date is Monday, October 3rd)

In the meantime, I'm looking forward to the PDD P2 OLE data...and the results from the FDA meeting for the next P3 PD or PDD trial.

Cheers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News